{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-264152","form_type":"8-K","ticker":"TYRA","cik":"0001863127","company_name":"Tyra Biosciences, Inc.","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.175219+00:00","generated_at":"2026-06-09T08:50:52.694094+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Tyra Biosciences amends bylaws to adopt universal proxy rules and enhance stockholder proposal disclosure","bullets":["Board approved amended bylaws effective Oct 26, 2023.","Amendments require compliance with SEC Rule 14a-19 for proxy solicitations supporting non-Board nominees.","Enhanced procedural and disclosure requirements for stockholder director nominations and other business proposals.","Includes technical, modernizing and clarifying changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-264152","json":"https://secwatch.observer/filing/0001193125-23-264152.json","markdown":"https://secwatch.observer/filing/0001193125-23-264152.md","text":"https://secwatch.observer/filing/0001193125-23-264152.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1863127/000119312523264152/0001193125-23-264152-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1863127/000119312523264152/d537796d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T08:50:52.694094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"406c2146403fd4a67b6a81c7b5a33273742226ec","claim":"Tyra Biosciences, Inc.: Amended and restated bylaws to address universal proxy rules and enhance stockholder nomination procedures (effective 2023-10-26).","evidence_excerpt":"On October 26, 2023, the Board of Directors (the Board) of Tyra Biosciences, Inc. (the Company) approved and adopted amended and restated bylaws (the Amended and Restated Bylaws), which became effective the same day.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312523264152/0001193125-23-264152-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-26"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}